These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12384246)

  • 21. Guidelines for the pathoanatomical examination of the lower brain stem in ingestive and swallowing disorders and its application to a dysphagic spinocerebellar ataxia type 3 patient.
    Rüb U; Brunt ER; Del Turco D; de Vos RA; Gierga K; Paulson H; Braak H
    Neuropathol Appl Neurobiol; 2003 Feb; 29(1):1-13. PubMed ID: 12581335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3.
    Schmidt J; Schmidt T; Golla M; Lehmann L; Weber JJ; Hübener-Schmid J; Riess O
    J Neurochem; 2016 Jul; 138(1):150-62. PubMed ID: 26990650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.
    Li X; Liu H; Fischhaber PL; Tang TS
    Prog Neurobiol; 2015 Sep; 132():34-58. PubMed ID: 26123252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease.
    Nascimento-Ferreira I; Santos-Ferreira T; Sousa-Ferreira L; Auregan G; Onofre I; Alves S; Dufour N; Colomer Gould VF; Koeppen A; Déglon N; Pereira de Almeida L
    Brain; 2011 May; 134(Pt 5):1400-15. PubMed ID: 21478185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The correlation between magnetic resonance imaging features of the brainstem and cerebellum and clinical features of spinocerebellar ataxia 3/Machado-Joseph disease.
    Liang X; Jiang H; Chen C; Zhou G; Wang J; Zhang S; Lei L; Wang X; Tang B
    Neurol India; 2009; 57(5):578-83. PubMed ID: 19934555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3).
    Hübener J; Weber JJ; Richter C; Honold L; Weiss A; Murad F; Breuer P; Wüllner U; Bellstedt P; Paquet-Durand F; Takano J; Saido TC; Riess O; Nguyen HP
    Hum Mol Genet; 2013 Feb; 22(3):508-18. PubMed ID: 23100324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDK5 protects from caspase-induced Ataxin-3 cleavage and neurodegeneration.
    Liman J; Deeg S; Voigt A; Voßfeldt H; Dohm CP; Karch A; Weishaupt J; Schulz JB; Bähr M; Kermer P
    J Neurochem; 2014 Jun; 129(6):1013-23. PubMed ID: 24548080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ophthalmological Features of Machado-Joseph Disease.
    Rana AQ; Qureshi DT; Morshed M; Kachhvi ZM; Rana MA; Qureshi ARM
    J Coll Physicians Surg Pak; 2016 Nov; 26(11):137-139. PubMed ID: 28666509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anterior horn degeneration in Machado-Joseph disease.
    Pedroso JL; de Resende Pinto WB; de Souza PV; Andriotti C; Stavale JN; Barsottini OG
    J Neurol Sci; 2016 Sep; 368():290-1. PubMed ID: 27538651
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of NF-κB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons.
    Li YX; Sibon OCM; Dijkers PF
    J Neuroinflammation; 2018 Sep; 15(1):261. PubMed ID: 30205834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model.
    Toonen LJA; Overzier M; Evers MM; Leon LG; van der Zeeuw SAJ; Mei H; Kielbasa SM; Goeman JJ; Hettne KM; Magnusson OT; Poirel M; Seyer A; 't Hoen PAC; van Roon-Mom WMC
    Mol Neurodegener; 2018 Jun; 13(1):31. PubMed ID: 29929540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in American families with spinocerebellar ataxia (SCA) type 3: SCA3 is allelic to Machado-Joseph disease.
    Higgins JJ; Nee LE; Vasconcelos O; Ide SE; Lavedan C; Goldfarb LG; Polymeropoulos MH
    Neurology; 1996 Jan; 46(1):208-13. PubMed ID: 8559377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spinocerebellar ataxia type 3/Machado-Joseph disease: segregation patterns and factors influencing instability of expanded CAG transmissions.
    Souza GN; Kersting N; Krum-Santos AC; Santos AS; Furtado GV; Pacheco D; Gonçalves TA; Saute JA; Schuler-Faccini L; Mattos EP; Saraiva-Pereira ML; Jardim LB
    Clin Genet; 2016 Aug; 90(2):134-40. PubMed ID: 26693702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bidirectional Connections between Depression and Ataxia Severity in Spinocerebellar Ataxia Type 3 Patients.
    Lin MT; Yang JS; Chen PP; Qian MZ; Lin HX; Chen XP; Shang XJ; Wang DN; Chen YC; Jiang B; Chen YJ; Chen WJ; Wang N; Gan SR
    Eur Neurol; 2018; 79(5-6):266-271. PubMed ID: 29763923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. n-Butylidenephthalide exhibits protection against neurotoxicity through regulation of tryptophan 2, 3 dioxygenase in spinocerebellar ataxia type 3.
    Rajamani K; Liu JW; Wu CH; Chiang IT; You DH; Lin SY; Hsieh DK; Lin SZ; Harn HJ; Chiou TW
    Neuropharmacology; 2017 May; 117():434-446. PubMed ID: 28223212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of an induced pluripotent stem cell line from a patient with spinocerebellar ataxia type 3 (SCA3): HIHCNi002-A.
    Hayer SN; Schelling Y; Huebener-Schmid J; Weber JJ; Hauser S; Schöls L
    Stem Cell Res; 2018 Jul; 30():171-174. PubMed ID: 29936336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalamic involvement in a spinocerebellar ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3) patient, and its clinical relevance.
    Rüb U; Del Turco D; Del Tredici K; de Vos RA; Brunt ER; Reifenberger G; Seifried C; Schultz C; Auburger G; Braak H
    Brain; 2003 Oct; 126(Pt 10):2257-72. PubMed ID: 12847080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spin labeling artery method perfusion MRI study of SPG4 and SCA3/MJD.
    Xing W; Wang XY; Liao XX; Liao WH; Shen L
    Magn Reson Imaging; 2014 Dec; 32(10):1330-4. PubMed ID: 25172988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age related axonal neuropathy in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD).
    Klockgether T; Schöls L; Abele M; Bürk K; Topka H; Andres F; Amoiridis G; Lüdtke R; Riess O; Laccone F; Dichgans J
    J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):222-4. PubMed ID: 10071104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich's ataxia.
    Stefanescu MR; Dohnalek M; Maderwald S; Thürling M; Minnerop M; Beck A; Schlamann M; Diedrichsen J; Ladd ME; Timmann D
    Brain; 2015 May; 138(Pt 5):1182-97. PubMed ID: 25818870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.